Recently, fusions between genes encoding ETS transcription factors and genes encoding prostate-specific genes, mostly TMPRSS2-ERG, have been reported as most frequent genetic alteration in early stages of human prostate cancer [58]. Here, ERG is linked to prostate carcinoma.